AMY POWELL: Open Payments
NPI 1194107045 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,762 in 88 payments from 21 companies in 2025. Trend: 2023 $1,647 · 2024 $1,689 · 2025 $4,762
Consulting: $2,390Food & beverage: $1,713Travel & lodging: $659
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $3,463 |
| Smith+Nephew, Inc. | 7 | $197 |
| ABBVIE INC. | 9 | $168 |
| ViiV Healthcare Company | 5 | $115 |
| PFIZER INC. | 6 | $113 |
| Amgen Inc. | 6 | $101 |
| Astellas Pharma US Inc | 5 | $96 |
| Indivior Inc. | 5 | $92 |
| Insmed, Inc. | 4 | $74 |
| Organogenesis Inc. | 3 | $59 |
Products named: Epclusa, EVENITY, Veozah, MAVYRET, SUBLOCADE, GRAFIX PL, DOVATO, Arikayce.
Industry payments across PA — which companies pay providers there.
